Bioactivity of dietary polyphenols: The role of metabolites

Critical Reviews in Food Science and Nutrition

Volumn 60, Issue 4, 2020, Pages 626-659

  Luca, Simon Vlad ^a,b   Macovei, Irina ^a   Bujor, Alexandra ^a   Miron, Anca ^a   Skalicka Woźniak, Krystyna ^b   Aprotosoaie, Ana Clara ^a   Trifan, Adriana ^a  

^a GRIGORE T POPA UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

^b MEDICAL UNIVERSITY OF LUBLIN   (Poland)

Author keywords

bioactive metabolites; curcumin; ellagitannins; low oral bioavailability; proanthocyanidins; Resveratrol

Indexed keywords

BIOCHEMISTRY; BIOMOLECULES; CELL PROLIFERATION; CELL SIGNALING; FLAVONOIDS; REDOX REACTIONS; RESVERATROL;

BIOLOGICAL FUNCTIONS; CURCUMIN; ELLAGITANNINS; ENZYMATIC ACTIVITIES; ORAL BIOAVAILABILITIES; PHYSIOLOGICAL PROCESS; PROANTHOCYANIDINS; SIGNALING TRANSDUCTION;

METABOLITES;

POLYPHENOL; RESVERATROL;

BIOAVAILABILITY; DIET; DRUG EFFECT; HUMAN; INTESTINE FLORA; METABOLISM;

BIOLOGICAL AVAILABILITY; DIET; GASTROINTESTINAL MICROBIOME; HUMANS; POLYPHENOLS; RESVERATROL;

EID: 85077871124     PISSN: 10408398     EISSN: 15497852     Source Type: Journal    
DOI: 10.1080/10408398.2018.1546669     Document Type: Review

References (279)

1. Abuelsaad, A. S. A., I., Mohamed, G., Allam, and A. A., Al-Solumani. 2013. Antimicrobial and immunomodulating activities of hesperidin and ellagic acid against diarrheic. Aeromonas hydrophila in a murine model. Life Sciences 93 (20):714–722. doi: 10.1016/j.lfs.2013.09.019.
2. Aggarwal, B. B., L., Deb, and S., Prasad. 2014. Curcumin differs from tetrahydrocurcumin for molecular targets, signaling pathways and cellular responses. Molecules 20 (1):185–205. doi: 10.3390/molecules20010185.
3. Aggarwal, B. B., C., Sundaram, N., Malani, and H., Ichikawa. 2007. Curcumin: The Indian solid gold. Advances in Experimental Medicine and Biology 595:1–75. In The molecular targets and therapeutic uses of curcumin in health and disease, ed B.B. Aggarwal, Y.J. Surh and S. Shishodia. Boston: Springer.
4. Aires, V., D., Delmas, C., Le Bachelier, N., Latruffe, D., Schlemmer, J. F., Benoist, F., Djouadi, J., Bastin. 2014. Stilbenes and resveratrol metabolites improve mitochondrial fatty acid oxidation defects in human fibroblasts. Orphanet Journal of Rare Diseases 9 (1):79. doi: 10.1186/1750-1172-9-79.
5. Aires, V., E., Limagne, A. K., Cotte, N., Latruffe, F., Ghiringhelli, and D., Delmas. 2013. Resveratrol metabolites inhibit human metastatic colon cancer cells progression and synergize with chemotherapeutic drugs to induce cell death. Molecular Nutrition & Food Research 57 (7):1170–1181. doi: 10.1002/mnfr.201200766.
6. Alamolhodaei, N. S., A. M., Tsatsakis, M., Ramezani, A. W., Hayes, and G., Karimi. 2017. Resveratrol as MDR reversion molecule in breast cancer: An overview. Food and Chemical Toxicology: An International Journal Published for the British Industrial Biological Research Association 103:223–232.
7. Amri, A., J. C., Chaumeil, S., Sfar, and C., Charrueau. 2012. Administration of resveratrol: What formulation solutions to bioavailability limitations? Journal of Controlled Release: official Journal of the Controlled Release Society 158 (2):182–193.
8. Anand, P., A. B., Kunnumakkara, R. A., Newman, and B. B., Aggarwal. 2007. Bioavailability of curcumin: Problems and promises. Molecular Pharmaceutics 4 (6):807–818.
9. Angeloni, C., J. P. E., Spencer, E., Leoncini, P. L., Biagi, and S., Hrelia. 2007. Role of quercetin and its in vivo metabolites in protecting H9c2 cells against oxidative stress. Biochimie 89 (1):73–82.
10. Asai, A., and T., Miyazawa. 2000. Occurrence of orally administered curcuminoid as glucuronide and glucuronide/sulfate conjugates in rat plasma. Life Science 67(23):2785–2793. doi: 10.1016/S0024-3205(00)00868-7.
11. Aslan, A., O., Gok, O., Erman, and T., Kuloglu. 2018. Ellagic acid impedes carbontetrachloride-induced liver damage in rats through suppression of NF-κB, Bcl-2 and regulating nrf-2 and caspase pathway. Biomedicine & Pharmacotherapy 105:662–669. doi: 10.1016/j.biopha.2018.06.020.
12. Baluchnejadmojarad, T., N., Rabiee, S., Zabihnejad, and M., Roghani. 2017. Ellagic acid exerts protective effect in intrastriatal 6-hydroxydopamine rat model of parkinson’s disease: Possible involvement of ERβ/Nrf2/HO-1 signaling. Brain Research 1662:23–30. doi: 10.1016/j.brainres.2017.02.021.
13. Bharathi, E., G., Jagadeesan, and M., Vijayakumar. 2014. Hepato-ameliorative effect of hesperidin and ellagic acid on mercuric chloride intoxicated rats. Biomedicine & Aging Pathology 4 (1):17–21. doi: 10.1016/j.biomag.2013.10.002.
14. st century solutions for an ancient conundrum. Current Drug Discovery Technologies 6 (3):192–199.
15. Bode, L. M., D., Bunzel, M., Huch, G. S., Cho, D., Ruhland, M., Bunzel, A., Bub, C. M. A. P., Franz, and S. E., Kulling. 2013. In vivo and in vitro metabolism of trans-resveratrol by human gut microbiota. The American Journal of Clinical Nutrition 97 (2):295–309.
16. Boesch-Saadtamnadi, C., A., Loboda, A. E., Wagner, A., Stachurska, A., Jozkowicz, J., Dulak, F., Doring, S., Wolffram, and G., Rimbach. 2011. Effect of quercetin and its metabolites isorhamnetin and quercetin-3-glucuronide on inflammatory gene expression: role of miR-155. The Journal of Nutritional Biochemistry 22:293–299. doi: 10.1016/j.jnutbio.2010.02.008.
17. Bosslet, K., R., Straub, M., Blumrich, J., Czech, M., Gerken, B., Sperker, H. K., Kroemer, J. P., Gesson, M., Koch, and C., Monneret. 1998. Elucidation of the mechanism enabling tumor selective prodrug monotherapy. Cancer Research 58 (6):1195–1201.
18. Brown, N. M., C. A., Belles, S. L., Lindley, L. D., Zimmer-Nechemias, X., Zhao, D. P., Witte, M. O., Kim, and K. D., Setchell. 2010. The chemopreventive action of equol enantiomers in a chemically induced animal model of breast cancer. Carcinogenesis 31 (5):886–893. doi: 10.1093/carcin/bgq025.
19. Burapan, S., M., Kim, and J., Han. 2017. Curcuminoid demethylation as an alternative metabolism by human intestinal microbiota. Journal of Agricultural and Food Chemistry 65(16):3305–3310. doi: 10.1021/acs.jafc.7b00943.
20. Bushman, B. S., B., Phillips, T., Isbell, B., Ou, J. M., Crane, and S. J., Knapp. 2004. Chemical composition of caneberry (Rubus spp.) seeds and oils and their antioxidant potential. Journal of Agricultural and Food Chemistry 52 (26):7982–7987.
21. Calamini, B., K., Ratia, M., Malkowski, M., Cuendet, J. M., Pezzuto, B. D., Santarsiero, and A. D., Mesecar. 2010. Pleiotropic mechanisms facilitated by resveratrol and its metabolites. Biochemical Journal 429 (2):273–282. doi: 10.1042/BJ20091857.
22. Cao, H., X. Q., Chen, A. R., Jassbi, and J. B., Xiao. 2015. Microbial biotransformation of bioactive flavonoids. Biotechnology Advances 33 (1):214–223.
23. Cao, H., J., Shi, X. P., Jia, J. B., Xiao, and X. Q., Chen. 2016. Non-covalent interaction between dietary stilbenoids and human serum albumin: Structure-affinity relationship, and its influence on the stability, free radical scavenging activity and cell uptake of stilbenoids. Food Chemistry 202:383–388. doi: 10.1016/j.foodchem.2016.02.003.
24. Carbonell-Capella, J. M., M., Buniowska, F. J., Barba, M. J., Esteve, and A., Frigola. 2014. Analytical methods for determining bioavailability and bioaccessibility of bioactive compounds from fruits and vegetables: A review. Comprehensive Reviews in Food Science and Food Safety 13 (2):155–177. doi: 10.1111/1541-4337.12049.
25. Cardona, F., C., Andrés-Lacueva, S., Tulipani, F. J., Tinahones, and M. I., Queipo-Ortuño. 2013. Benefits of polyphenols on gut microbiota and implications in human health. The Journal of Nutritional Biochemistry 24 (8):1415–1422.
26. Cervantes-Laurean, D., D. D., Schramm, E. L., Jacobson, I., Halaweish, G. G., Bruckner, and G. A., Boissonneault. 2006. Inhibition of advanced glycation end product formation on collagen by rutin and its metabolites. The Journal of Nutritional Biochemistry 17 (8):531–540.
27. Chen, C. Y., W. L., Yang, and S. Y., Kuo. 2011. Cytotoxic activity and cell cycle analysis of hexahydrocurcumin on SW 480 human colorectal cancer cells. Natural Product Communications 6 (11):1671–1672.
28. Chen, L., H., Teng, Z., Jia, M., Battino, A., Miron, Z., Yu, H., Cao, and J., Xiao. 2017. Intracellular signaling pathways of inflammation modulated by dietary flavonoids: The most recent evidence. Critical Reviews in Food Science and Nutrition 1–17. doi: 10.1080/10408398.2017.1345853.
29. Chen, P. T., Z. T., Chen, W. C., Hou, L. C., Yu, and R. P. Y., Chen. 2016. Polyhydroxycurcuminoids but not curcumin upregulate neprilysin and can be applied to the prevention of alzheimer’s disease. Scientific Reports 6:29760.
30. Cheng, A. L., C. H., Hsu, J. K., Lin, M. M., Hsu, Y. F., Ho, T. S., Shen, J. Y., Ko, J. T., Lin, B. R., Lin, W., Ming-Shiang, et al. 2001. Phase I clinical trial of curcumin, a chemopreventive agent, in patients with high-risk or pre-malignant lesions. Anticancer Research 21 (4B):2895–2900.
31. Chiou, Y. S., J. C., Wu, Q., Huang, F., Shahidi, Y. J., Wang, C. T., Ho, and M. H., Pan. 2014. Metabolic and colonic microbiota transformation may enhance the bioactivities of dietary polyphenols. Journal of Functional Foods 7:3–25. doi: 10.1016/j.jff.2013.08.006.
32. Choi, E. J., and G. H., Kim. 2013. O-desmethylangolensin inhibits the proliferation of human breast cancer MCF-7 cells by inducing apoptosis and promoting cell cycle arrest. Oncology Letters 6 (6):1784–1788. doi: 10.3892/ol.2013.1601.
33. Choi, E. J., J. I., Lee, and G. H., Kim. 2013. Anticancer effects of O-desmethylangolensin are mediated through cell cycle arrest at the G2/M phase and mitochondrial-dependent apoptosis in Hep3B human hepatocellular carcinoma cells. International Journal of Molecular Medicine 31 (3):726–730. doi: 10.3892/ijmm.2013.1230.
34. Choy, Y. Y., and A. L., Waterhouse. 2014. Proanthocyanidin metabolism, a mini review. Nutr. Aging 2:111–116.
35. Cires, M. J., X., Wong, C., Carrasco-Pozo, and M., Gotteland. 2017. The gastrointestinal tract as a key target organ for the health-promoting effects of dietary proanthocyanidins. Frontiers in Nutrition 3 (57):57.
36. Corbett, S., J., Daniel, R., Drayton, M., Field, R., Steinhardt, and N., Garret. 2010. Evaluation of the anti-inflammatory effects of ellagic acid. Journal of Perianesthesia Nursing: Official Journal of the American Society of Perianesthesia Nurses 25 (4):214–220.
37. Cretu, E., A., Trifan, A., Vasincu, and A., Miron. 2012. Plant-derived anticancer agents - curcumin in cancer prevention and treatment. Revista medico-chirurgicala a Societatii de Medici si Naturalisti din Iasi 116:1223–1229.
38. Cui, G. H., W. Q., Chen, and Z. Y., Shen. 2018. Urolithin a shows anti-atherosclerotic activity via activation of class B scavenger receptor and activation of Nef2 signaling pathway. Pharmacological Reports 70 (3):519–524. doi: 10.1016/j.pharep.2017.04.020.
39. Da Silva, E. L., M. K., Piskula, N., Yamamoto, J. H., Moon, and J., Terao. 1998. Quercetin metabolites inhibit copper ion-induced lipid peroxidation in rat plasma. FEBS Letters 430 (3):405–408. doi: 10.1016/S0014-5793(98)00709-1.
40. Dajas, F. 2012. Life or death: neuroprotective and anticancer effects of quercetin. Journal of Ethnopharmacology 143 (2):383–396.
41. Davinelli, S., G., Scapagnini, F., Marzatico, V., Nobile, N., Ferrara, and G., Corbi. 2017. Influence of equol and resveratrol supplementation on health-related quality of life in menopausal women: a randomized, placebo-controlled study. Maturitas 96:77–83. doi: 10.1016/j.maturitas.2016.11.016.
42. Day, A. J., Y., Bao, M. R. A., Morgan, and G., Williamson. 2000. Conjugation position of quercetin glucuronides and effect on biological activity. Free Radical Biology and Medicine 29 (12):1234–1243. doi: 10.1016/S0891-5849(00)00416-0.
43. Del Bas, J. M., J., Fernández-Larrea, M., Blay, A., Ardèvol, M. J., Salvadó, L., Arola, and C., Bladé. 2005. Grape seed procyanidins improve atherosclerotic risk index and induce liver CYP7A1 and SHP expression in healthy rats. The FASEB Journal 19 (3):479–481. doi: 10.1096/fj.04-3095fje.
44. Delgado, L., I., Fernandes, S., González-Manzano, V., de Freitas, N., Mateus, and C., Santos-Buelga. 2014. Anti-proliferative effects of quercetin and catechin metabolites. Food & Function 5 (4):797–803. doi: 10.1039/c3fo60441a.
45. Del Rio, D., L. G., Costa, M. E., Lean, and A., Crozier. 2010. Polyphenols and health: What compounds are involved? Nutrition, Metabolism & Cardiovascular Diseases 20 (1):1–6. doi: 10.1016/j.numecd.2009.05.015.
46. Dempe, J. S., R. K., Scheerle, E., Pfeiffer, and M., Metzler. 2013. Metabolism and permeability of curcumin in cultured caco-2 cells. Molecular Nutrition & Food Research 57 (9):1543–1549.
47. den Besten, G., K., van Eunen, A. K., Groen, K., Venema, D. J., Reijngoud, and B. M., Bakker. 2013. The role of short-chain fatty acids in the interplay between diet, gut microbiota, and host energy metabolism. Journal of Lipid Research 54 (9):2325–2340. doi: 10.1194/jlr.R036012.
48. Deprez, S., I., Mila, J. F., Huneau, D., Tome, and A., Scalbert. 2001. Transport of proanthocyanidin dimer, trimer, and polymer across monolayers of human intestinal epithelial caco-2 cells. Antioxid. Redox Signal 3 (6):957–967. doi: 10.1089/152308601317203503.
49. Deters, M., H., Knochenwefel, D., Lindhorst, T., Koal, H. H., Meyer, W., Hänsel, K., Resch, and V., Kaever. 2008. Different curcuminoids inhibit T-lymphocyte proliferation independently of their radical scavenging activities. Pharmaceutical Research 25 (8):1822–1827. doi: 10.1007/s11095-008-9579-2.
50. Dhingra, D., and A., Jangra. 2014. Antiepileptic activity of ellagic acid, a naturally occurring polyphenolic compound, in mice. Journal of Functional Foods 10:364–369. doi: 10.1016/j.jff.2014.07.011.
51. Di Donna, L., D., Taverna, S., Indelicato, A., Napoli, G., Sindona, and F., Mazzotti. 2017. Rapid assay of resveratrol in red wine by paper spray tandem mass spectrometry and isotope dilution. Food Chemistry 229:354–357.
52. Dileep, K. V., I., Tintu, and C., Sadasivan. 2011. Molecular docking studies of curcumin analogs with phospholipase A2. Interdisciplinary Sciences, Computational Life Sciences 3(3):189–197.
53. Dytrtová, J. J., M., Straka, K., Bělonožníková, M., Jakl, and H., Ryšlavá. 2018. Does resveratrol retain its antioxidative properties in wine? Redox behaviour of resveratrol in the presence of Cu(II) and tebuconazole. Food Chemistry 262:221–225.
54. Dong, H. P., R. C., Yang, I. C., Chunag, L. J., Huang, H. T., Li, H. L., Chen, and C. Y., Chen. 2012. Inhibitory effect of hexahydrocurcumin on human platelet aggregation. Natural Product Communications 7(7):883–884.
55. Duenas, M., S., Gonzalez-Manzano, A., Gonzalez-Paramas, and C., Santos-Buelga. 2010. Antioxidant evaluation of O-methylated metabolites of catechin, epicatechin and quercetin. J. Pharm. Biomed. Anal 51:443–449. doi: 10.1016/j.jpba.2009.04.007.
56. Edwards, R. L., P. B., Luis, P. V., Varuzza, A. I., Joseph, S. H., Presley, R., Chaturvedi, and C., Schneider. 2017. The anti-inflammatory activity of curcumin is mediated by its oxidative metabolites. The Journal of Biological Chemistry 292(52):21243–21252.
57. Egert, S., S., Wolffram, A., Bosy-Westphal, C., Boesch-Saadatmandi, A. E., Wagner, J., Frank, G., Rimbach, and M. J., Mueller. 2008. Daily quercetin supplementation dose-dependently increases plasma quercetin concentrations in healthy humans. The Journal of Nutrition 138(9):1615–1621. doi: 10.1093/jn/138.9.1615.
58. El Khawand, T., A., Courtois, J., Valls, T., Richard, and S., Krisa. 2018. A review of dietary stilbenes: Sources and bioavailability. Phytochemistry Reviews. doi: 10.1007/s11101-018-9578-9579.
59. Elghali, S., S., Mustafa, M., Amid, M. Y., Manap, A., Ismail, and F., Abas. 2012. Bioconversion of daidzein to equol by Bifidobacterium breve 15700 and Bifidobacterium longum BB536. Journal of Functional Foods 4 (4):736–745. doi: 10.1016/j.jff.2012.04.013.
60. Esatbeyoglu, T., P., Huebbe, I. M., Ernst, D., Chin, A. E., Wagner, and G., Rimbach. 2012. Curcumin-from molecule to biological function. Angewandte Chemie (International ed. In English) 51 (22):5308–5332.
61. Eseberri, I., A., Lasa, I., Churruca, and M. P., Portillo. 2013. Resveratrol metabolites modify adipokine expression and secretion in 3T3-L1 pre-adipocytes and mature adipocytes. Plos One 8 (5):e63918. doi: 10.1371/journal.pone.0063918.
62. Espín, J. C., A., González-Sarrías, and F. A., Tomás-Barberán. 2017. The gut microbiota: A key factor in the therapeutic effects of (poly)phenols. Biochem. Pharmacol 139:82–93. doi: 10.1016/j.bcp.2017.04.033.
63. Espín, J. C., R., Gonzalez-Barrio, B., Cerda, C., Lopez-Bote, A. I., Rey, and F. A., Tomás-Barberán. 2007. Iberian pig as a model to clarify obscure points in the bioavailability and metabolism of ellagitannins in humans. Journal of Agricultural and Food Chemistry 55 (25):10476–10485. doi: 10.1021/jf0723864.
64. European Food Safety Authority (EFSA). 2014. Refined exposure assessment for curcumin (E 100). EFSA Journal 12 (10):3876.
65. Fabjanowicz, M., J., Płotka-Wasylka, and J., Namieśnik. 2018. Detection, identification and determination of resveratrol in wine. Problems and challenges. Trends in Analytical Chemistry 103:21–33. doi: 10.1016/j.trac.2018.03.006.
66. Feliciano, R. P., A., Boeres, L., Massacessi, G., Istas, M. R., Ventura, C., Nunes Dos Santos, C., Heiss, and A., Rodriguez-Mateos. 2016. Identification and quantification of novel cranberry-derived plasma and urinary (poly)phenols. Archives of Biochemistry and Biophysics 599:31–41. doi: 10.1016/j.abb.2016.01.014.
67. Firdaus, F., M. F., Zafeer, E., Anis, M., Ahmad, and M., Afzal. 2018. Ellagic acid attenuates arsenic induced neuro-inflammation and mitochondrial dysfunction associated apoptosis. Toxicology Reports 5:411–417. doi: 10.1016/j.toxrep.2018.02.017.
68. Foti, P., D., Erba, P., Riso, A., Spadafranca, F., Criscuoli, and G., Testolin. 2005. Comparison between daidzein and genistein antioxidant activity in primary and cancer lymphocytes. Archives of Biochemistry and Biophysics 433 (2):421–427. doi: 10.1016/j.abb.2004.10.008.
69. Franke, A. A., J. F., Lai, and B. M., Halm. 2014. Absorption, distribution, metabolism, and excretion of isoflavonoids after soy intake. Archives of Biochemistry and Biophysics 559:24–28. doi: 10.1016/j.abb.2014.06.007.
70. Frankenfeld, C. L. 2011. O-Desmethylangolensin: the importance of equol's lesser known cousin to human health. Advances in Nutrition (Bethesda, Md.) 2 (4):317–324.
71. Gambini, J., M., Ingles, G., Olaso, R., Lopez-Grueso, V., Bonet-Costa, L., Gimeno-Mallench, C., Mas-Bargues, K. M., Abdelaziz, M. C., Gomez-Cabrera, J., Vina, and C., Borras. 2015. Properties of resveratrol: in vitro and in vivo studies about metabolism, bioavailability, and biological effects in animal models and humans. Oxidative Medicine and Cellular Longevity 2015:837042. doi: 10.1155/2015/837042.
72. Gan, R. Y., H. B., Li, Z. Q., Sui, and H., Corke. 2018. Absorption, metabolism, anti-cancer effect and molecular targets of epigallocatechin gallate (EGCG): an updated review. Critical Reviews in Food Science and Nutrition 58 (6):924–941. doi: 10.1080/10408398.2016.1231168.
73. Gao, K., A., Xu, C., Krul, K., Venema, Y., Liu, Y., Niu, J., Lu, L., Bensoussan, N. P., Seeram, D., Heber, and S. M., Henning. 2006. Of the major phenolic acids formed during human microbial fermentation of tea, citrus, and soy flavonoid supplements, only 3,4-dihydroxyphenylacetic acid has antiproliferative activity. The Journal of Nutrition 136 (1):52–57. doi: 10.1093/jn/136.1.52.
74. Garcea, G., D. P., Berry, D. J., Jones, R., Singh, A. R., Dennison, P. B., Farmer, R. A., Sharma, W. P., Steward, and A. J., Gescher. 2005. Consumption of the putative chemopreventive agent curcumin by cancer patients: Assessment of curcumin levels in the colorectum and their pharmacodynamic consequences. Cancer Epidemiology, Biomarkers & Prevention 14 (1):120–125.
75. Garcea, G., Jones, D. J. R., Singh, A. R., Dennison, P. B., Farmer, R. A., Sharma, R. A. W. P., Steward, A. J., Gescher, and D. P., Berry. 2004. Detection of curcumin and its metabolites in hepatic tissue and portal blood of patients following oral administration. British Journal of Cancer 90 (5):1011–1015. doi: 10.1038/sj.bjc.6601623.
76. García-Niño, W. R., and C., Zazueta. 2015. Ellagic acid: Pharmacological activities and molecular mechanisms involved in liver protection. Pharmacological Research 97:84–103. doi: 10.1016/j.phrs.2015.04.008.
77. García-Villalba, R., J. C., Espín, and F. A., Tomás-Barberán. 2016. Chromatographic and spectroscopic characterization of urolithins for their determination in biological samples after the intake of foods containing ellagitannins and ellagic acid. Journal of Chromatography A 1428:162–175. doi: 10.1016/j.chroma.2015.08.044.
78. Gardner, C. D., L. M., Chatterjee, and A. A., Franke. 2009. Effects of isoflavone supplements vs. soy foods on blood concentrations of genistein and daidzein in adults. The Journal of Nutritional Biochemistry 20 (3):227–234.
79. Gaya, P., A., Peirotén, and J. M., Landete. 2017. Transformation of plant isoflavones into bioactive isoflavones by lactic acid bacteria and bifidobacteria. J. Funct. Foods 39:198–205. doi: 10.1016/j.jff.2017.10.029.
80. Gaya, P., A., Peirotén, M., Medina, I., Álvarez, and J. M., Landete. 2018. Bifidobacterium pseudocatenulatum INIA P815: The first bacterium able to produce urolithins a and B from ellagic acid. Journal of Functional Foods 45:95–99. doi: 10.1016/j.jff.2018.03.040.
81. Giuliani, C., M., Iezzi, L., Ciolli, A., Hysi, I., Bucci, S., Di Santo, C., Rossi, M., Zucchelli, and G., Napolitano. 2017. Resveratrol has anti-thyroid effects both in vitro and in vivo. Food and Chemical Toxicology: An International Journal Published for the British Industrial Biological Research Association 107 (Pt A):237–247.
82. Glabasnia, A., and T., Hofmann. 2006. Sensory-directed identification of taste-active ellagitannins in American (Quercus Alba L.) and european oak wood (Quercus robur L.) and quantitative analysis in bourbon whiskey and oak-matured red wine. Journal of Agricultural and Food Chemistry 54 (9):3380–3390. doi: 10.1021/jf052617b.
83. Glasser, G., E. U., Graefe, F., Struck, M., Veit, and R., Gebhardt. 2002. Comparison of antioxidative capacities and inhibitory effects on cholesterol biosynthesis of quercetin and potential metabolites. Phytomedicine 9:33–40. doi: 10.1078/0944-7113-00080.
84. González-Sarrías, A., R., García-Villalba, M. A., Núñez-Sánchez, J., Tomé-Carneiro, P., Zafrilla, J., Mulero, F. A., Tomás-Barberán, and J. C., Espín. 2015. Identifying the limits for ellagic acid bioavailability: A crossover pharmacokinetic study in healthy volunteers after consumption of pomegranate extracts. Journal of Functional Foods 19:225–235. doi: 10.1016/j.jff.2015.09.019.
85. Gordon, O. N., P. B., Luis, H. O., Sintim, and C., Schneider. 2015. Unraveling curcumin degradation: autoxidation proceeds through spiroepoxide and vinylether intermediates en route to the main bicyclopentadione. Journal of Biological Chemistry 290 (8):4817–4828. doi: 10.1074/jbc.M114.618785.
86. Gotteland, M., M., Andrews, M., Toledo, L., Muñoz, P., Caceres, A., Anziani, E., Wittig, H., Speisky, and G., Salazar. 2008. Modulation of Helicobacter pylori colonization with cranberry juice and Lactobacillus johnsonii La1 in children. Nutrition 24 (5):421–426. doi: 10.1016/j.nut.2008.01.007.
87. Guerrero, L., M., Margalef, Z., Pons, M., Quiñones, L., Arola, A., Arola-Arnal, and B., Muguerza. 2013. Serum metabolites of proanthocyanidin-administered rats decrease lipid synthesis in HepG2 cells. The Journal of Nutritional Biochemistry 24 (12):2092–2099. doi: 10.1016/j.jnutbio.2013.08.001.
88. Gullon, B., T. A., Lu-Chau, M. T., Moreira, J. M., Lema, and G., Eibes. 2017. Rutin: A review on extraction, identification and purification methods, biological activities and approaches to enhance its bioavailability. Trends in Food Science and Technology 67:220–235. doi: 10.1016/j.tifs.2017.07.008.
89. Guo, Y., and R. S., Bruno. 2015. Endogenous and exogenous mediators of quercetin bioavailability. The Journal of Nutritional Biochemistry 26 (3):201–210.
90. Guyot, S., N., Marnet, and J., Drilleau. 2001. Thiolysis-HPLC characterization of apple procyanidins covering a large range of polymerization states. Journal of Agricultural and Food Chemistry 49(1):14–20. doi: 10.1021/jf000814z.
91. Hämäläinen, M., R., Nieminen, P., Vuorela, M., Heinonen, and E., Moilanen. 2007. Anti-inflammatory effects of flavonoids: Genistein, kaempferol, quercetin and daidzein inhibit STAT-1 and NF-kappaB activations, whereas flavone, isorhamnetin, naringenin, and pelargonidin inhibit only NF-kappaB activation along with their inhibitory effect on iNOS expression and NO production in activated macrophages. Mediators of Inflammation 2007:45673. doi: 10.1155/2007/45673.
92. Hara-Terawaki, A., A., Takagaki, H., Kobayashi, and F., Nanjo. 2017. Inhibitory activity of catechin metabolites produced by intestinal microbiota on proliferation of HeLa cells. Biological and Pharmaceutical Bulletin 40 (8):1331–1335. doi: 10.1248/bpb.b17-00127.
93. Haron, H., A., Ismail, A., Azlan, S., Shahar, and L. S., Peng. 2009. Daidzein and genistein contents in tempeh and selected soy products. Food Chemistry 115 (4):1350–1356. doi: 10.1016/j.foodchem.2009.01.053.
94. Hassaninasab, A., Y., Hashimoto, K., Tomita-Yokotani, and M., Kobayashi. 2011. Discovery of the curcumin metabolic pathway involving a unique enzyme in an intestinal microorganism. Proceedings of the National Academy of Sciences of the United States of America 108 (16):6615–6620. doi: 10.1073/pnas.1016217108.
95. He, Y., W., Niu, C., Xia, and B., Cao. 2016. Daidzein reduces the proliferation and adiposensess of 3T3-L1 preadipocytes via regulating adipogenic gene expression. Journal of Functional Foods 22:446–453. doi: 10.1016/j.jff.2016.01.044.
96. He, Y., H. Z., Zeng, Y., Yu, J. S., Zhang, X. P., Duan, X. N., Zeng, F. T., Gong, Q., Liu, and B., Yang. 2017. Resveratrol improves prostate fibrosis during progression of urinary dysfunction in chronic prostatitis. Environmental Toxicology and Pharmacology 54:120–124. doi: 10.1016/j.etap.2017.06.025.
97. Heger, M., R. F., van Golen, M., Broekgaarden, and M. C., Michel. 2014. The molecular basis for the pharmacokinetics and pharmacodynamics of curcumin and its metabolites in relation to cancer. Pharmacological Reviews 66 (1):222–307.
98. Heilman, J., P., Andreux, N., Tran, C., Rinsch, and W., Blanco-Bose. 2017. Safety assessment of urolithin A, a metabolite produced by the human gut microbiota upon dietary intake of plant derived ellagitannins and ellagic acid. Food and Chemical Toxicology 108:289–297. doi: 10.1016/j.fct.2017.07.050.
99. Heinonen, S. M., A., Hoikkala, K., Wähälä, and H., Adlercreutz. 2003. Metabolism of the soy isoflavones daidzein, genistein and glycitein in human subjects. Identification of new metabolites having an intact isoflavonoid skeleton. The Journal of Steroid Biochemistry and Molecular Biology 87 (4–5):285–299. doi: 10.1016/j.jsbmb.2003.09.003.
100. Heleno, S. A., A., Martins, M. J., Queiroz, and I. C., Ferreira. 2015. Bioactivity of phenolic acids: metabolites versus parent compounds: A review. Food Chemistry 173:501–513.
101. Henning, S. M., P. H., Summanen, R. P., Lee, J., Yang, S. M., Finegold, D., Heber, and Z., Li. 2017. Pomegranate ellagitannins stimulate the growth of Akkermansia muciniphila in vivo. Anaerobe 43:56–60. doi: 10.1016/j.anaerobe.2016.12.003.
102. Henning, S. M., J. J., Choo, and D., Heber. 2008. Nongallated compared with gallated flavan-3-ols in green and black tea are more bioavailable. The Journal of Nutrition 138 (8):1529S–1534S.
103. Herranz-Lopez, M., I., Borras-Linares, M., Olivares-Vicente, J., Galvez, A., Segura-Carretero, and V., Micol. 2017. Correlation between the cellular metabolism of quercetin and its glucuronide metabolite and oxidative stress in hypertrophied 3T3-L1 adipocytes. Phytomedicine 25:25–28. doi: 10.1016/j.phymed.2016.12.008.
104. Hewlings, S. J., and D. S., Kalman. 2017. Curcumin: A review of its' effects on human health. Foods 6(10)pii: E92. doi: 10.3390/foods6100092.
105. Hoehle, S. I., E., Pfeiffer, and M., Metzler. 2007. Glucuronidation of curcuminoids by human microsomal and recombinant UDP-glucuronosyltransferases. Molecular NutritionFood Research 51 (8):932–938.
106. Högger, P. 2013. Nutrition-derived bioactive metabolites produced by gut microbiota and their potential impact on human health. Nutrition and Medicine 1 (1):1.
107. Hong, J., J. D., Lambert, S. H., Lee, P. J., Sinko, and C. S., Yang. 2003. Involvement of multidrug resistance-associated proteins in regulating cellular levels of (-)-epigallocatechin-3-gallate and its methyl metabolites. Biochemical and Biophysical Research Communications 310 (1):222–227. doi: 10.1016/j.bbrc.2003.09.007.
108. Hong, J. I., M., Bose, J. Y., Ju, J. H., Ryu, X. X., Chen, S. M., Sang, M. J., Lee, and C. S., Yang. 2004. Modulation of arachidonic acid metabolism by curcumin and related beta-diketone derivatives: Effects on cytosolic phospholipase A, cyclooxygenases and 5-lipoxygenase. Carcinogenesis 25 (9):1671–1679. doi: 10.1093/carcin/bgh165.
109. Hoshino, J., E. J., Park, T. P., Kondratyuk, L., Marler, J. M., Pezzuto, R. B., van Breemen, S., Mo, Y., Li, and M., Cushman. 2010. Selective synthesis and biological evaluation of sulfate-conjugated resveratrol metabolites. Journal of Medicinal Chemistry 53 (13):5033–5043. doi: 10.1021/jm100274c.
110. Hrelia, S., and C., Angeloni. 2013. Quercetin and its metabolites in heart health. In: Bioactive food as dietary interventions for cardiovascular disease, ed. R. R., Watson and V. R., Preedy, 217–228. San Diego: Academic Press.
111. Huang, M.-T., W., Ma, Y.-P., Lu, R. L., Chang, C., Fisher, P. S., Manchand, H. L., Newmark, A. H., Conney, and M., You. 1995. Effects of curcumin, demethoxycurcumin, bisdemethoxycurcumin and tetrahydrocurcumin on 12-O-tetradecanoylphorbol-13-acetate-induced tumor promotion. Carcinogenesis 16 (10):2493–2497. doi: 10.1093/carcin/16.10.2493.
112. Huang, Y., S., Cao, Q., Zhang, H., Zhang, Y., Fan, F., Qiu, and N., Kang. 2018. Biological and pharmacological effects of hexahydrocurcumin, a metabolite of curcumin. Archives of Biochemistry and Biophysics 646:31–37.
113. Hwang, C. S., H. S., Kwak, H. J., Lim, S. H., Lee, Y. S., Kang, T. B., Choe, H. G., Hur, and K. O., Han. 2006. Isoflavone metabolites and their in vitro dual functions: they can act as an estrogenic agonist or antagonist depending on the estrogen concentration. The Journal of Steroid Biochemistry and Molecular Biology 101 (4–5):246–253.
114. Ireson, C., S., Orr, D. J., Jones, R., Verschoyle, C. K., Lim, J. L., Luo, L., Howells, S., Plummer, R., Jukes, M., Williams, W. P., et al. 2001. Characterization of metabolites of the chemopreventive agent curcumin in human and rat hepatocytes and in the rat in vivo, and evaluation of their ability to inhibit phorbol ester-induced prostaglandin E2 production. Cancer Research 61 (3):1058–1064.
115. Ireson, C. R., D. J., Jones, S., Orr, M. W., Coughtrie, D. J., Boocock, M. L., Williams, P. B., Farmer, W. P., Steward, and A. J., Gescher. 2002. Metabolism of the cancer chemopreventive agent curcumin in human and rat intestine. Cancer Epidemiology, Biomarkers & Prevention 11 (1):105–111.
116. Jaric, I., J., Zivanovic, M., Miler, V., Ajdzanovic, D., Blagojevic, N., Ristic, V., Milosevic, and N., Nestorovic. 2018. Genistein and daidzein treatments differently affect uterine homeostasis in the ovary-intact middle-aged rats. Toxicology and Applied Pharmacology 339:73–84. doi: 10.1016/j.taap.2017.12.001.
117. Jenner, A. M., J., Rafter, and B., Halliwell. 2005. Human fecal water content of phenolics: The extent of colonic exposure to aromatic compounds. Free Radical Biology and Medicine 38 (6):763–772. doi: 10.1016/j.freeradbiomed.2004.11.020.
118. Justino, G. C., M. R., Santos, S., Canario, C., Borges, M. H., Florencio, and L., Mira. 2004. Plasma quercetin metabolites: Structure-antioxidant activity relationships. Archives of Biochemistry and Biophysics 432 (1):109–121. doi: 10.1016/j.abb.2004.09.007.
119. Khopde, S. M., K. I., Priyadarsini, S. N., Guha, J. G., Satav, P., Venkatesan, and M. N. A., Rao. 2000. Inhibition of radiation-induced lipid peroxidation by tetrahydrocurcumin: possible mechanisms by pulse radiolysis. Bioscience, Biotechnology, and Biochemistry 64 (3):503–509. doi: 10.1271/bbb.64.503.
120. Kida, K., M., Suzuki, N., Matsumoto, F., Nanjo, and Y., Hara. 2000. Identification of biliary metabolites of (-)-epigallocatechin gallate in rats. Journal of Agricultural and Food Chemistry 48 (9):4151–4155.
121. Kim, E. Y., J. Y., Shin, Y. J., Park, and A. K., Kim. 2014. Equol induces mitochondria-mediated apoptosis of human cervical cancer cells. Cancer Research 34:4985–4992.
122. Kim, J. M., S., Araki, D. J., Kim, C. B., Park, N., Takasuka, H., Baba-Toriyama, T., Ota, Z., Nir, F., Khachik, N., Shimidzu, et al. 1998. Chemopreventive effects of carotenoids and curcumins on mouse Colon carcinogenesis after 1,2-dimethylhydrazine initiation. Carcinogenesis 19 (1):81–85. doi: 10.1093/carcin/19.1.81.
123. Ko, Y. H., S. Y., Kim, S. Y., Lee, and C. G., Jang. 2018. 6,7,4’-Trihydroxyisoflavone, a major metabolite of daidzein, improves learning and memory via the cholinergic system and the p-CREB/BDNF signaling pathway in mice. European Journal of Pharmacology 826:140–147. doi: 10.1016/j.ejphar.2018.02.048.
124. Kocaadam, B., and N., Şanlier. 2017. Curcumin, an active component of turmeric (Curcuma longa), and its effects on health. Critical Reviews in Food Science and Nutrition 57 (13):2889–2895.
125. Komatsu, W., H., Kishi, K., Yagasaki, and S., Ohhira. 2018. Urolithin a attenuates pro-inflammatory mediator production by suppressing PI3-K/NF-κB and JNK/AP-1 signaling pathways in lipopolysaccharide-stimulated RAW264 macrophages: possible involvement of NADPH oxidase-derived reactive oxygen species. European Journal of Pharmacology 833: 411–424. doi:10.1016/j.ejphar.2018.06.023.
126. Kunati, S. R., S., Yang, B. M., William, and Y., Xu. 2018. An LC-MS/MS method for simultaneous determination of curcumin, curcumin glucuronide and curcumin sulfate in a phase II clinical trial. Journal of Pharmaceutical and Biomedical Analysis 156:189–198. doi: 10.1016/j.jpba.2018.04.034.
127. Lambert, J. D., J. E., Rice, J., Hong, Z., Hou, and C. S., Yang. 2005. Synthesis and biological activity of the tea catechin metabolites, M4 and M6 and their methoxy-derivatives. Bioorganic & Medicinal Chemistry Letters 15 (4):873–876. doi: 10.1016/j.bmcl.2004.12.070.
128. Landete, J. M. 2011. Ellagitannins, ellagic acid and their derived metabolites: A review about source, metabolism, functions and health. Food Research International 44 (5):1150–1160. doi: 10.1016/j.foodres.2011.04.027.
129. Lao, C. D., M. T., Ruffin, D., Normolle, D. D., Heath, S. I., Murray, J. M., Bailey, M. E., Boggs, J., Crowell, C. L., Rock, and D. E., Brenner. 2006. Dose escalation of a curcuminoid formulation. BMC Complementary and Alternative Medicine 6:10.
130. Larrosa, M., A., González-Sarrías, M. T., García-Conesa, F. A., Tomás-Barberán, and J. C., Espín. 2006. Urolithins, ellagic-acid derived metabolites produced by human colonic microflora, exhibit estrogenic and antiestrogenic activities. Journal of Agricultural and Food Chemistry 54 (5):1611–1620. doi: 10.1021/jf0527403.
131. Larrosa, M., A., González-Sarrías, M. J., Yáñez-Gascón, M. V., Selma, M., Azorín-Ortuño, S., Toti, F., Tomás-Barberán, P., Dolara, and J. C., Espín. 2010. Anti-inflammatory properties of a pomegranate extract and its metabolite urolithin-A in a colitis rat model and the effect of Colon inflammation on phenolic metabolism. The Journal of Nutritional Biochemistry 21(8):717–725. doi: 10.1016/j.jnutbio.2009.04.012.
132. Lasa, A., I., Churruca, I., Eseberri, C., Andrés-Lacueva, and M. P., Portillo. 2012. Delipidating effect of resveratrol metabolites in 3T3-L1 adipocytes. Molecular Nutrition & Food Research 56 (10):1559–1568. doi: 10.1002/mnfr.201100772.
133. Le Donne, M., M., Lentini, A., Alibrandi, V., Salimbeni, G., Giuffre', F., Mazzeo, O., Triolo, and R., D'Anna. 2017. Antiviral activity of ellagic acid and annona muricata in cervical HPV related pre-neoplastic lesions: A randomized trial. Journal of Functional Foods 35:549–554. doi: 10.1016/j.jff.2017.06.006.
134. Lee, C. C., J. H., Kim, J. S., Kim, Y. S., Oh, S. M., Han, J. H. Y., Park, K. W., Lee, and C. Y., Lee. 2017. 5-(3′,4′-Dihydroxyphenyl-γ-valerolactone), a major microbial metabolite of proanthocyanidin, attenuates THP-1 monocyte-endothelial adhesion. International Journal of Molecular Sciences 18 (7):1–12.
135. Lee, D. E., K. W., Lee, S. K., Jung, E. J., Lee, J. A., Hwang, T. G., Lim, B. Y., Kim, A. M., Bode, H. J., Lee, and Z., Dong. 2011. 6,7,4’- Trihydroxyisoflavone inhibits HCT-116 human Colon cancer cell proliferation by targeting CDK1 and CDK2. Carcinogenesis 32 (4):629–635. doi: 10.1093/carcin/bgr008.
136. Lee, G., J. S., Park, E. J., Lee, J. H., Ahn, and H. S., Kim. 2018. Anti-inflammatory and antioxidant mechanisms of urolithin B in activated microglia. Phytomedicine 55: 50–57. doi: 10.1016/j.phymed.2018.06.032.
137. Lee, S. J., T. A., Vuong, G. Y., Go, Y. J., Song, S., Lee, S. Y., Lee, S. W., Kim, J., Lee, Y. K., Kim, D. W., Seo, et al. 2017. An isoflavone compound daidzein elicits myoblast differentiation and myotube growth. Journal of Functional Foods 38:438–446. doi: 10.1016/j.jff.2017.09.016.
138. Lee, S. L., W. J., Huang, W. W., Lin, S. S., Lee, and C. H., Chen. 2005. Preparation and anti-inflammatory activities of diarylheptanoid and diarylheptylamine analogs. Bioorganic & Medicinal Chemistry 13 (22):6175–6181.
139. Lesjak, M., I., Beara, N., Simin, D., Pintac, T., Majkic, K., Bekvalac, D., Orcic, and N., Mimica-Dukic. 2018. Antioxidant and anti-inflammatory activities of quercetin and its derivatives. Journal of Functional Foods 40:68–75. doi: 10.1016/j.jff.2017.10.047.
140. Li, F., V., Nitteranon, X., Tang, J., Liang, G., Zhang, K. L., Parkin, and Q., Hu. 2012. In vitro antioxidant and anti-inflammatory activities of 1-dehydro-[6]-gingerdione, 6-shogaol, 6-dehydroshogaol and hexahydrocurcumin. Food Chemistry 135 (2):332–337. doi: 10.1016/j.foodchem.2012.04.145.
141. Li, S., X., Li, A., Shpigelman, J. M., Lorenzo, D., Montesano, and F. J., Barba. 2017. Direct and indirect measurements of enhanced phenolic bioavailability from litchi pericarp procyanidins by Lactobacillus casei-01. Food & Function 8 (8):2760–2770. doi: 10.1039/C7FO00749C.
142. Liang, X. L., X. L., Wang, Z., Li, Q. H., Hao, and S. Y., Wang. 2010. Improved in vitro assays of superoxide anion and 1,1-diphenyl-2-picrylhydrazyl (DPPH) radical-scavenging activity of isoflavones and isoflavone metabolites. Journal of Agricultural and Food Chemistry 58 (22):11548–11552. doi: 10.1021/jf102372t.
143. Liggins, J., L. J. C., Bluck, S., Runswick, C., Atkinson, C. W. A., Coward, and S. A., Bingham. 2000. Daidzein and genistein content of fruits and nuts. The Journal of Nutritional Biochemistry 11 (6):326–331. doi: 10.1016/S0955-2863(00)00085-1.
144. Lin, I. C., S., Yamashita, M., Murata, M., Kumazoe, and H., Tachibana. 2016. Equol suppresses inflammatory response and bone erosion due to rheumatoid arthritis in mice. The Journal of Nutritional Biochemistry 32:101–106. doi: 10.1016/j.jnutbio.2016.02.012.
145. Liu, X., N., Suzuki, Y. R. S., Laxmi, Y., Okamoto, and S., Shibutani. 2012. Anti-breast cancer potential of daidzein in rodents. Life Sciences 91(11–12):415–419.
146. Liu, Z., Z., Xie, W., Jones, R. E., Pavlovicz, S., Liu, J., Yu, P. K., Li, J., Lin, J. R., Fuchs, G., Marcucci, et al. 2009. Curcumin is a potent DNA hypomethylation agent. Bioorganic & Medicinal Chemistry Letters 19(3):706–709.
147. Gu, L., M. A., Kelm, J. F., Hammerstone, G., Beecher, J., Holden, D., Haytowitz, S., Gebhardt, and R. L., Prior. 2004. Concentrations of proanthocyanidins in common foods and estimations of normal consumption. The Journal of Nutrition 134 (3):613–617.
148. Lodi, F., R., Jimenez, L., Moreno, P. A., Kroon, P. W., Needs, D. A., Hughes, C., Santos-Buelga, A., Gonzalez-Paramas, A., Cogolludo, R., Lopez-Sepulveda, et al. 2009. Glucuronidated and sulfated metabolites of the flavonoid quercetin prevent endothelial dysfunction but lack direct vasorelaxant effects in rat aorta. Atherosclerosis 204 (1):34–39. doi: 10.1016/j.atherosclerosis.2008.08.007.
149. Lou, Y., J., Zheng, H., Hu, J., Lee, and S., Zeng. 2015. Application of ultra-performance liquid chromatography coupled with quadrupole time-of-flight mass spectrometry to identify curcumin metabolites produced by human intestinal bacteria. Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences 985:38–47. doi: 10.1016/j.jchromb.2015.01.014.
150. Lu, H., X., Meng, C., Li, S., Sang, C., Patten, S., Sheng, J., Hong, N., Bai, B., Winnik, C. T., Ho, and C. S., Yang. 2003. Glucuronides of tea catechins: Enzymology of biosynthesis and biological activities. Drug Metabolism and Disposition 31 (4):452–461. doi: 10.1124/dmd.31.4.452.
151. Luca, S. V., A. C., Aprotosoaie, and A., Miron. 2016. The antigenotoxic potential of flavonoids. Phytochemistry Reviews 15 (4):591–625. doi: 10.1007/s11101-016-9457-1.
152. Lutz, M., A., Martínez, and E. A., Martínez. 2013. Daidzein and genistein contents in seeds of quinoa (Chenopodium quinoa willd.) from local ecotypes grown in arid Chile. Industrial Crops and Products 49:117–121. doi: 10.1016/j.indcrop.2013.04.023.
153. Mahalingam, S., L., Gao, M., Gonnering, W., Helferich, and J. A., Flaws. 2016. Equol inhibits growth, induces atresia, and inhibits steroidogenesis of mouse antral follicles in vitro. Toxicology and Applied Pharmacology 295:47–55. doi: 10.1016/j.taap.2016.02.009.
154. Mahran, R. I., M. M., Hagras, D., Sun, and D. E., Brenner. 2017. Bringing curcumin to the clinic in cancer prevention: A review of strategies to enhance bioavailability and efficacy. The Aaps Journal 19(1):54–81.
155. Mallebrera, B., A., Maietti, P., Tedeschi, G., Font, M. J., Ruiz, and V., Brandolini. 2017. Antioxidant capacity of trans-resveratrol dietary supplements alone or combined with the mycotoxin beauvericin. Food and Chemical Toxicology: An International Journal Published for the British Industrial Biological Research Association 105:315–318.
156. Marczylo, T. H., R. D., Verschoyle, D. N., Cooke, P., Morazzoni, W. P., Steward, and A. J., Gescher. 2007. Comparison of systemic availability of curcumin with that of curcumin formulated with phosphatidylcholine. Cancer Chemotherapy and Pharmacology 60 (2):171–177. doi: 10.1007/s00280-006-0355-x.
157. Marin, L., E. M., Miguélez, C. J., Villar, and F., Lombó. 2015. Bioavailability of dietary polyphenols and gut microbiota metabolism: antimicrobial properties. BioMed Research International 2015:905215. doi: 10.1155/2015/905215.
158. Maruo, T., M., Sakamoto, C., Ito, T., Toda, and Y., Benno. 2008. Adlercreutzia equolfaciens gen. nov., sp. Nov., an equol-producing bacterium isolated from human faeces, and emended description of the genus eggerthella. International Journal of Systematic and Evolutionary Microbiology 58 (5):1221–1227. doi: 10.1099/ijs.0.65404-0.
159. Masumoto, S., A., Terao, Y., Yamamoto, T., Mukai, T., Miura, and T., Shoji. 2016. Non-absorbable apple procyanidins prevent obesity associated with gut microbial and metabolomic changes. Scientific Reports 6:31208.
160. Mele, L., S., Carobbio, N., Brindani, C., Curti, S., Rodriguez-Cuenca, G., Bidault, P., Mena, I., Zanotti, M., Vacca, A., Vidal-Puig, and D., Del Rio. 2017. Phenyl-γ-valerolactones, flavan-3-ol colonic metabolites, protect brown adipocytes from oxidative stress without affecting their differentiation or function. Molecular Nutrition & Food Research 61 (9):1700074. doi: 10.1002/mnfr.201700074.
161. Mele, L., P., Mena, A., Piemontese, V., Marino, N., López-Gutiérrez, F., Bernini, F., Brighenti, I., Zanotti, and D., Del Rio. 2016. Antiatherogenetic effects of ellagic acid and urolithins in vitro. Archives of Biochemistry and Biophysics 599:42–50. doi: 10.1016/j.abb.2016.02.017.
162. Mena, P., D., González de Llano, N., Brindani, A., Esteban-Fernandez, C., Curti, M. V., Moreno-Arribas, D., del Rio, and B., Bartolome. 2017. 5-(3′,4′-Dihydroxyphenyl)-γ-valerolactone and its sulphate conjugates, representative circulating metabolites of flavan-3-ols, exhibit anti-adhesive activity against uropathogenic Escherichia coli in bladder epithelial cells. Journal of Functional Foods 29:275–280. doi: 10.1016/j.jff.2016.12.035.
163. Metzler, M., E., Pfeiffer, S., Schulz, and J. S., Dempe. 2013. Jan-Feb. Curcumin uptake and metabolism. Biofactors (Oxford, England) 39 (1):14–20.
164. Mitani, K., S., Narimatsu, and H., Kataoka. 2003. Determination of daidzein and genistein in soybean foods by automated on-line in-tube solid-phase microextraction coupled to high-performance liquid chromatography. Journal of Chromatography A 986 (2):169–177. doi: 10.1016/S0021-9673(02)02014-9.
165. Monagas, M., M., Urpi-Sarda, F., Sánchez-Patán, R., Llorach, I., Garrido, C., Gómez-Cordovés, C., Andres-Lacueva, and B., Bartolomé. 2010. Insights into the metabolism and microbial biotransformation of dietary flavan-3-ols and the bioactivity of their metabolites. Food & Function 1 (3):233–253. doi: 10.1039/c0fo00132e.
166. Moohammadaree, A., C., Changtam, P., Wicha, A., Suksamrarn, J., Tocharus, and C., Tocharus. 2015. Mechanisms of vasorelaxation induced by hexahydrocurcuminin isolated rat thoracic aorta. Phytotherapy Research 29 (11):1806–1813. doi: 10.1002/ptr.5448.
167. Morales, N. P., S., Sirijaroonwong, P., Yamanont, and C., Phisalaphong. 2015. Electron paramagnetic resonance study of the free radical scavenging capacity of curcumin and its demethoxy and hydrogenated derivatives. Biological and Pharmaceutical Bulletin 38 (10):1478–1483. doi: 10.1248/bpb.b15-00209.
168. Morton, M. S., A., Matos-Ferreira, L., Abranches-Monteiro, R., Correia, N., Blacklock, P. S., Chan, C., Cheng, S., Lloyd, W., Chieh-Ping, and K., Griffiths. 1997. Measurement and metabolism of isoflavonoids and lignans in the human male. Cancer Letters 114(1–2):145–151.
169. Mujic, I., E., Sertovic, S., Jokic, Z., Saric, V., Alibabic, S., Vidovic, and J., Zivkovik. 2011. Isoflavone content and antioxidant properties of soybean seeds. Croatian Journal of Food Science and Technology 3:16–20.
170. Mukhopadhyay, A., N., Basu, N., Ghatak, and P. K., Gujral. 1982. Anti-inflammatory and irritant activities of curcumin analogues in rats. Agents and Actions 12 (4):508–515.
171. Murphy, M. M., L. M., Barraj, D., Herman, X., Bi, R., Cheatham, and R. K., Randolph. 2012. Phytonutrient intake by adults in the United States in relation to fruit and vegetable consumption. Journal of the Academy of Nutrition and Dietetics 112 (2):222–229.
172. Murugan, P., and L., Pari. 2007. Influence of tetrahydrocurcumin on erythrocyte membrane bound enzymes and antioxidant status in experimental type 2 diabetic rats. Journal of Ethnopharmacology 113 (3):479–486.
173. Nankar, R. P., and M., Doble. 2017. Hybrid drug combination: Anti-diabetic treatment of type 2 diabetic wistar rats with combination of ellagic acid and pioglitazone. Phytomedicine 37:4–9. doi: 10.1016/j.phymed.2017.10.014.
174. Neilson, A. P., S. F., O'Keefe, and B. W., Bolling. 2016. High-molecular-weight proanthocyanidins in foods: overcoming analytical challenges in pursuit of novel dietary bioactive components. Annual Review of Food Science and Technology 7 (1):43–64. doi: 10.1146/annurev-food-022814-015604.
175. Núñez-Sánchez, M. A., A., Karmokar, A., González-Sarrías, R., García-Villalba, F. A., Tomás-Barberán, M. T., García-Conesa, K., Brown, and J. C., Espín. 2016. In vivo relevant mixed urolithins and ellagic acid inhibit phenotypic and molecular colon cancer stem cell features: a new potentiality for ellagitannin metabolites against cancer. Food and Chemical Toxicology 92:8–16. doi: 10.1016/j.fct.2016.03.011.
176. Okada, K., C., Wangpoengtrakul, T., Tanaka, S., Toyokuni, K., Uchida, and T., Osawa. 2001. Curcumin and especially tetrahydrocurcumin ameliorate oxidative stress-induced renal injury in mice. The Journal of Nutrition 131 (8):2090–2095.
177. Okoko, T., and I. F., Oruambo. 2009. Inhibitory activity of quercetin and its metabolite on lipopolysaccharide-induced activation of macrophage U937 cells. Food and Chemical Toxicology: An International Journal Published for the British Industrial Biological Research Association 47 (4):809–812.
178. Ortiz-Ruiz, C. V., J., Berna, J., Tudela, R., Varon, and F., Garcia-Canovas. 2016. Action of ellagic acid on the melanin biosynthesis pathway. Journal of Dermatological Science 82 (2):115–122.
179. Ou, K., and L., Gu. 2014. Absorption and metabolism of proanthocyanidins. Journal of Functional Foods 7:43–53. doi: 10.1016/j.jff.2013.08.004.
180. Ozdal, T., D. A., Sela, J., Xiao, D., Boyacioglu, F., Chen, and E., Capanoglu. 2016. The reciprocal interactions between polyphenols and gut microbiota and effects on bioaccessibility. Nutrients 8 (2):78. doi: 10.3390/nu8020078.
181. Pan, M. H., T. M., Huang, and J. K., Lin. 1999. Biotransformation of curcumin through reduction and glucuronidation in mice. Drug Metabolism and Disposition: The Biological Fate of Chemicals 27 (4):486–494.
182. Pan, M. H., S. Y., Lin-Shiau, and J. K., Lin. 2000. Comparative studies on the suppression of nitric oxide synthase by curcumin and its hydrogenated metabolites through down-regulation of IkappaB kinase and NFkappaB activation in macrophages. Biochemical Pharmacology 60 (11):1665–1676. doi: 10.1016/S0006-2952(00)00489-5.
183. Pashikanti, S., D. R., de Alba, G. A., Boissonneault, and D., Cervantes-Laurean. 2010. Rutin metabolites: Novel inhibitors of nonoxidative advanced glycation end products. Free Radical Biology and Medicine 48(5):656–663. doi: 10.1016/j.freeradbiomed.2009.11.019.
184. Patel, K. R., C., Andreadi, R. G., Britton, E., Horner-Glister, A., Karmokar, S., Sale, V. A., Brown, D. E., Brenner, R., Singh, W. P., Steward, et al. 2013. Sulfate metabolites provide an intracellular Pool for resveratrol generation and induce autophagy with senescence. Science Translational Medicine 5 (205):205ra133. doi: 10.1126/scitranslmed.3005870.
185. Pattanayak, R., P., Basak, S., Sen, and M., Bhattacharya. 2017. An insight to the binding of ellagic acid with human serum albumin using spectroscopic and isothermal calorimetry studies. Science Translational Medicine 10:88–93. doi: 10.1016/j.bbrep.2017.03.001.
186. Peng, Y., Y., Shi, H., Zhang, Y., Mine, and R., Tsao. 2017. Anti-inflammatory and anti-oxidative activities of daidzein and its sulfonic acid ester derivatives. Journal of Functional Foods 35:635–640. doi: 10.1016/j.jff.2017.06.027.
187. Pfeiffer, E., S. I., Hoehle, S. G., Walch, A., Riess, A. M., Sólyom, and M., Metzler. 2007. Curcuminoids form reactive glucuronides in vitro. Journal of Agricultural and Food Chemistry 55 (2):538–544.
188. Pfundstein, B., R., Haubner, G., Würtele, N., Gehres, C. M., Ulrich, and R. W., Owen. 2014. Pilot walnut intervention study of urolithin bioavailability in human volunteers. Journal of Agricultural and Food Chemistry 62 (42):10264–10273. doi: 10.1021/jf5040652.
189. Pinkaew, D., C., Changtam, C., Tocharus, P., Govitrapong, P., Jumnongprakhon, A., Suksamrarn, and J., Tocharus. 2016. Association of neuroprotective effect of di-O-demethylcurcumin on Aβ25-35-induced neurotoxicity with suppression of NF-κB and activation of Nrf2. Neurotoxicity Research 29 (1):80–91.
190. Piwowarski, J. P., I., Stanislawska, S., Granica, J., Stefanska, and A. K., Kiss. 2017. Phase II conjugates of urolithins isolated from human urine and potential role of β-glucuronidases in their disposition. Drug Metabolism and Disposition 45 (6):657–665. doi: 10.1124/dmd.117.075200.
191. Polycarpou, E., L. B., Meira, S., Carrington, E., Tyrrell, H., Midjatahedi, and M. A., Carew. 2013. Resveratrol 3-O-D-glucuronide and resveratrol 4′-O-D-glucuronide inhibit Colon cancer cell growth: evidence for a role of A3 adenosine receptors, cyclin D1 depletion, and G1 cell cycle arrest. Molecular Nutrition & Food Research 57 (10):1708–1717.
192. Prasad, S., A. K., Tyagi, and B. B., Aggarwal. 2014. Recent developments in delivery, bioavailability, absorption and metabolism of curcumin: The golden pigment from golden spice. Cancer Research and Treatment 46 (1):2–18. doi: 10.4143/crt.2014.46.1.2.
193. Priyadarsini, K. I. 2014. The chemistry of curcumin: from extraction to therapeutic agent. Molecules (Basel, Switzerland) 19 (12):20091–20112.
194. Qiu, Z., B., Zhou, L., Jin, H., Yu, L., Liu, Y., Liu, C., Qin, S., Xie, and F., Zhu. 2013. In vitro antioxidant and antiproliferative effects of ellagic acid and its colonic metabolite, urolithins, on human bladder cancer T24 cells. Food and Chemical Toxicology 59:428–437. doi: 10.1016/j.fct.2013.06.025.
195. Rafii, F. 2015. The role of colonic bacteria in the metabolism of the natural isoflavone daidzin to equol. Metabolites 5 (1):56–73.
196. Rasouli, H., M. H., Farzaei, and R., Khodarahmi. 2017. Polyphenols and their benefits: A review. International Journal of Food Properties 20 (Suppl. 2):1700–1741. doi: 10.1080/10942912.2017.135401.
197. Rein, D., S., Lotito, R. R., Holt, C. L., Keen, H. H., Schmitz, and C. G., Fraga. 2000. Epicatechin in human plasma: In vivo determination and effect of chocolate consumption on plasma oxidation status. The Journal of Nutrition 130 (8):2109S–2114S. doi: 10.1093/jn/130.8.2109S.
198. Rein, M. J., M., Renouf, C., Cruz-Hernandez, L., Actis-Goretta, S. K., Thakkar, and M., da Silva Pinto. 2013. Bioavailability of bioactive food compounds: A challenging journey to bioefficacy. British Journal of Clinical Pharmacology 75 (3):588–602.
199. Richelle, M., S., Pridmore-Merten, S., Bodenstab, M., Enslen, and E. A., Offord. 2002. Hydrolysis of isoflavone glycosides to aglycones by β-glycosidase does not alter plasma and urine isoflavone pharmacokinetics in postmenopausal woman. The Journal of Nutrition 132 (9):2587–2592. doi: 10.1093/jn/132.9.2587.
200. Romo-Vaquero, M., R., García-Villalba, A., González-Sarrías, D., Beltrán, F. A., Tomás-Barberán, J. C., Espín, and M. V., Selma. 2015. Interindividual variability in the human metabolism of ellagic acid: Contribution of gordinobacter to urolithin production. Journal of Functional Foods 17:785–791. doi: 10.1016/j.jff.2015.06.040.
201. Rowland, I., M., Faughnan, L., Hoey, K., Wähälä, G., Williamson, and A., Cassidy. 2003. Bioavailability of phyto-oestrogens. British Journal of Nutrition 89:45–58.
202. Rowland, I., H., Wiseman, T., Sanders, H., Adlercreutz, and E., Bowey. 1999. Metabolism of oestrogens and phytoestrogens: role of the gut microflora. Biochemical Society Transactions 27 (2):304–308.
203. Sak, K., H., Lust, M., Kase, and J., Jaal. 2018. Cytotoxic action of methylquercetins in human lung adenocarcinoma cells. Oncology Letters 15 (2):1973–1978.
204. Sanchez-Patan, F., M., Chioua, I., Garrido, C., Cueva, A., Samadi, J., Marco-Contelles, M. V., Moreno-Arribas, B., Bartolome, and B. M., Monagas. 2011. Synthesis, analytical features, and biological relevance of 5-(3′,4′-dihydroxyphenyl)-γ-valerolactone, a microbial metabolite derived from the catabolism of dietary flavan-3-ols. Journal of Agricultural and Food Chemistry 59 (13):7083–7091. doi: 10.1021/jf2020182.
205. Schiborr, C., A., Kocher, D., Behnam, J., Jandasek, S., Toelstede, and J., Frank. 2014. The oral bioavailability of curcumin from micronized powder and liquid micelles is significantly increased in healthy humans and differs between sexes. Molecular Nutrition & Food Research 58 (3):516–527. doi: 10.1002/mnfr.201300724.
206. Schneider, C., O. N., Gordon, R. L., Edwards, and P. B., Luis. 2015. Degradation of curcumin: From mechanism to biological implications. Journal of Agricultural and Food Chemistry 63 (35):7606–7614.
207. Schoefer, L., R., Mohan, A., Braune, M., Birringer, and M., Blaut. 2002. Anaerobic C-ring cleavage of genistein and daidzein by Eubacterium ramulus. FEMS Microbiology Letters 208 (2):197–202.
208. Schroeter, A., I. A., Groh, G., Del Favero, M., Pignitter, K., Schueller, V., Somoza, and D., Marko. 2015. Inhibition of topoisomerase II by phase II metabolites of resveratrol in human Colon cancer cells. Molecular NutritionFood Research 59 (12):2448–2459.
209. Schueller, K., M., Pignitter, and V., Somoza. 2015. Sulfated and glucuronated trans-resveratrol metabolites regulate chemokines and sirtuin-1 expression in U-937 macrophages. Journal of Agricultural and Food Chemistry 63 (29):6535–6545. doi: 10.1021/acs.jafc.5b01830.
210. Selma, M. V., D., Beltrán, R., García-Villalba, J. C., Espín, and F. A., Tomás-Barberán. 2014. Description of urolithin production capacity from ellagic acid of two human intestinal gordonibacter species. Food & Function 5 (8):1779–1784. doi: 10.1039/C4FO00092G.
211. Selma, M. V., D., Beltrán, M. C., Luna, M., Romo-Vaquero, R., García-Villalba, A., Mira, J. C., Espín, and F. A., Tomás-Barberán. 2017. Isolation of human intestinal bacteria capable of producing the bioactive metabolite isourolithin a from ellagic acid. Frontiers in Microbiology 8:1521.
212. Selma, M. V., A., González-Sarrías, J., Salas-Salvadó, C., Andrés-Lacueva, C., Alasalvar, A., Örem, F. A., Tomás-Barberán, and J. C., Espín. 2018. The gut microbiota metabolism of pomegranate or walnut ellagitannins yields two urolithin-metabotypes that correlate with cardiometabolic risk biomarkers: comparison between normoweight, overweight-obesity and metabolic syndrome. Clinical Nutrition (Edinburgh, Scotland) 37 (3):897–905.
213. Seo, S. G., H., Yang, S. H., Shin, S., Min, Y. A., Kim, J. G., Yu, D. E., Lee, M. Y., Chung, Y. S., Heo, J. Y., Kwon, et al. 2013. A metabolite of daidzein, 6,7,4’-trihydroxyisoflavone, suppress adipogenesis in 3T3-L1 preadipocytes via ATP-competitive inhibition of PI3K. Molecular Nutrition & Food Research 57 (8):1446–1455. doi: 10.1002/mnfr.201200593.
214. Setchell, K. D. R., N. M., Brown, P., Desai, and L., Zimmer-Nechemias. 2001. Bioavailability of pure isoflavones in healthy humans and analysis of commercial soy isoflavone supplements. Journal of Nutrition 131:1362–1375.
215. Setchell, K. D. R., N. M., Brown, and E., Lydeking-Olsen. 2002. The clinical importance of the metabolite equol-a clue to the effectiveness of soy and its isoflavones. The Journal of Nutrition 132 (12):3577–3584.
216. Sharma, R. A., S. A., Euden, S. L., Platton, D. N., Cooke, A., Shafayat, H. R., Hewitt, T. H., Marczylo, B., Morgan, D., Hemingway, S. M., Plummer, et al. 2004. Phase I clinical trial of oral curcumin: Biomarkers of systemic activity and compliance. Clinical Cancer Research 10 (20):6847–6854. doi: 10.1158/1078-0432.CCR-04-0744.
217. Sharma, R. A., H. R., McLelland, K. A., Hill, C. R., Ireson, S. A., Euden, M. M., Manson, M., Pirmohamed, L. J., Marnett, A. J., Gescher, and W. P., Steward. 2001. Pharmacodynamic and pharmacokinetic study of oral curcuma extract in patients with colorectal cancer. Clinical Cancer Research 7 (7)1900.
218. Shen, Y., K. D., Croft, J. M., Hodgson, R., Kyle, I. L. E., Lee, Y., Wang, R., Stocker, and N. C., Ward. 2012. Quercetin and its metabolites improve vessel function by inducing eNOS activity via phosphorylation of AMPK. Biochemical Pharmacology 84 (8):1036–1044. doi: 10.1016/j.bcp.2012.07.016.
219. Shoba, G., D., Joy, T., Joseph, M., Majeed, R., Rajendran, and P. S., Srinivas. 1998. Influence of piperine on the pharmacokinetics of curcumin in animals and human volunteers. Planta Medica 64 (4):353–356.
220. Shoji, M., K., Nakagawa, A., Watanabe, T., Tsuduki, T., Yamada, S., Kuwahara, F., Kimura, and T., Miyazawa. 2014. Comparison of the effects of curcumin and curcumin glucuronide in human hepatocellular carcinoma HepG2 cells. Food Chemistry 151:126–132. doi: 10.1016/j.foodchem.2013.11.021.
221. Sies, H. 2010. Polyphenols and health: Update and perspectives. Archives of Biochemistry and Biophysics 501 (1):2–5.
222. Singletary, K. W., and B., Meline. 2001. Effect of grape seed proanthocyanidins on colon aberrant crypts and breast tumors in a rat dual-organ tumor model. Nutrition and Cancer 39 (2):252–258.
223. Somparn, P., C., Phisalaphong, S., Nakornchai, S., Unchern, and N. P., Morales. 2007. Comparative antioxidant activities of curcumin and its demethoxy and hydrogenated derivatives. Biological & Pharmaceutical Bulletin 30 (1):74–78. doi: 10.1248/bpb.30.74.
224. Srimuangwong, K., C., Tocharus, P., Yoysungnoen Chintana, A., Suksamrarn, and J., Tocharus. 2012. Hexahydrocurcumin enhances inhibitory effect of 5-fluorouracil on HT-29 human colon cancer cells. World Journal of Gastroenterology 18 (19):2383–2389. doi: 10.3748/wjg.v18.i19.2383.
225. Srimuangwong, K., C., Tocharus, J., Tocharus, A., Suksamrarn, and P. Y., Chintana. 2012. Effects of hexahydrocurcumin in combination with 5-fluorouracil on dimethylhydrazine-induced colon cancer in rats. World Journal of Gastroenterology 18 (47):6951–6959. doi: 10.3748/wjg.v18.i47.6951.
226. Stanić, Z. 2017. Curcumin, a compound from natural sources, a true scientific challenge–A review. Plant Foods for Human Nutrition (Dordrecht, Netherlands) 72 (1):1–12.
227. Stanislawska, I. J., J. P., Piwowarski, S., Granica, and A. K., Kiss. 2018. The effects of urolithins on the response of prostate cancer cells to non-steroidal antiandrogen bicalutamide. Phytomedicine doi: 10.1016/j.phymed.2018.03.054.
228. Stevens, J. F., and C. S., Maier. 2016. The chemistry of gut microbial metabolism of polyphenols. Phytochemistry Reviews: Proceedings of the Phytochemical Society of Europe 15 (3):425–444.
229. Storniolo, C. E., and J. J., Moreno. 2012. Resveratrol metabolites have an antiproliferative effect on intestinal epithelial cancer cells. Food Chemistry 134(3):1385–1391. doi: 10.1016/j.foodchem.2012.03.036.
230. Suri, S., X. H., Liu, S., Rayment, D. A., Hughes, P. A., Kroon, P. W., Needs, M. A., Taylor, S., Tribolo, and V. G., Wilson. 2010. Quercetin and its major metabolites selectively modulate cyclic GMP-dependent relaxations and associated tolerance in pig isolated coronary artery. British Journal of Pharmacology 159 (3):566–575. doi: 10.1111/j.1476-5381.2009.00556.x.
231. Suri, S., M. A., Taylor, A., Verity, S., Tribolo, P. W., Needs, P. A., Kroon, D. A., Hughes, and V. G., Wilson. 2008. A comparative study of the effects of quercetin and its glucuronide and sulfate metabolites on human neutrophil function in vitro. Biochemical Pharmacology 76 (5):645–653. doi: 10.1016/j.bcp.2008.06.010.
232. Takagaki, A., and F., Nanjo. 2015. Effects of metabolites produced from (-)-epigallocatechin gallate by rat intestinal bacteria on angiotensin I-converting enzyme activity and blood pressure in spontaneously hypertensive rats. Journal of Agricultural and Food Chemistry 63 (37):8262–8266. doi: 10.1021/acs.jafc.5b03676.
233. Takagaki, A., Y., Kato, and F., Nanjo. 2014. Isolation and characterization of rat intestinal bacteria involved in biotransformation of (-)-epigallocatechin. Archives of Microbiology 196 (10):681–695.
234. Takagaki, A., S., Otani, and F., Nanjo. 2011. Antioxidative activity of microbial metabolites of (-)-epigallocatechin gallate produced in rat intestines. Bioscience, Biotechnology, and Biochemistry 75 (3):582–585. doi: 10.1271/bbb.100683.
235. Tamura, M., T., Tsushida, and K., Shinohara. 2007. Isolation of an isoflavone-metabolizing, Clostridium-like bacterium, strain TM-40, from human feces. Anaerobe 13 (1):32–35. doi: 10.1016/j.anaerobe.2006.10.001.
236. Tang, F., Y. X., Xie, H., Cao, H., Yang, X. Q., Chen, and J. B., Xiao. 2017. Fetal bovine serum influences the stability and bioactivity of resveratrol analogues: A polyphenol-protein interaction approach. Food Chemistry 219:321–328. doi: 10.1016/j.foodchem.2016.09.154.
237. Tang, Y., S., Nakashima, S., Saiki, Y., Myoi, N., Abe, S., Kuwazuru, B., Zhu, H., Ashida, Y., Murata, and Y., Nakamura. 2016. 3,4-Dihydroxyphenylacetic acid is a predominant biologically-active catabolite of querceting glycosides. Food Research International 89:716–723. doi: 10.1016/j.foodres.2016.09.034.
238. Tayyem, R. F., D. D., Heath, W. K., Al-Delaimy, and C. L., Rock. 2006. Curcumin content of turmeric and curry powders. Nutrition and Cancer 55 (2):126–131.
239. Teng, H., and L., Chen. 2018. Polyphenols and bioavailability: An update. Critical Reviews in Food Science and Nutrition 6:0. doi: 10.1080/10408398.2018.1437023
240. Tocharus, J., S., Jamsuwan, C., Tocharus, C., Changtam, and A., Suksamrarn. 2012. Curcuminoid analogs inhibit nitric oxide production from LPS-activated microglial cells. Journal of Natural Medicines 66 (2):400–405. doi: 10.1007/s11418-011-0599-6.
241. Tomás-Barberán, F. A., R., Garcia-Villalba, A., Gonzalez-Sarrias, M. V., Selma, and J. C., Espin. 2014. Ellagic acid metabolism by human gut microbiota: consistent observation of three urolithin phenotypes in intervention trials, independent of food source, age, and health status. Journal of Agricultural and Food Chemistry 62 (28):6535–6538. doi: 10.1021/jf5024615.
242. Tomás-Barberán, F. A., A., González-Sarrías, R., García-Villalba, M. A., Núñez-Sánchez, M. V., Selma, M. T., García-Conesa, and J. C., Espín. 2017. Urolithins, the rescue of “old” metabolites to understand a “new” concept: metabotypes as a nexus among phenolic metabolism, microbiota dysbiosis, and host health status. Molecular Nutrition & Food Research 61 (1). doi: 10.1002/mnfr.201500901.
243. Tome-Carneiro, J., M., Larrosa, A., Gonzalez-Sarrias, F. A., Tomas-Barberan, M. T., Garcia-Conesa, and J. C., Espin. 2013. Resveratrol and clinical trials: The crossroad from in vitro studies to human evidence. Current Pharmaceutical Design 19:6064–6093. doi: 10.2174/13816128113199990407.
244. Tzounis, X., A., Rodriguez-Mateos, J., Vulevic, G. R., Gibson, C., Kwik-Uribe, and J. P., Spencer. 2011. Prebiotic evaluation of cocoa-derived flavanols in healthy humans by using a randomized, controlled, double-blind, crossover intervention study. The American Journal of Clinical Nutrition 93 (1):62–72. doi: 10.3945/ajcn.110.000075.
245. Urpi-Sarda, M., M., Monagas, N., Khan, R. M., Lamuela-Raventos, C., Santos-Buelga, E., Sacanella, M., Castell, J., Permanyer, and C., Andres-Lacueva. 2009. Epicatechin, procyanidins, and phenolic microbial metabolites after cocoa intake in humans and rats. Analytical and Bioanalytical Chemistry 394 (6):1545–1556. doi: 10.1007/s00216-009-2676-1.
246. Vareed, S. K., M., Kakarala, M. T., Ruffin, J. A., Crowell, D. P., Normolle, Z., Djuric, and D. E., Brenner. 2008. Pharmacokinetics of curcumin conjugate metabolites in healthy human subjects. Cancer Epidemiology, Biomarkers & Prevention 17 (6):1411–1417. doi: 10.1158/1055-9965.EPI-07-2693.
247. Verotta, L., L., Panzella, S., Antenucci, V., Calvenzani, F., Tomay, K., Petroni, E., Caneva, and A., Napolitano. 2018. Fermented pomegranate wastes as sustainable source of ellagic acid: Antioxidant properties, anti-inflammatory action, and controlled release under simulated digestion conditions. Food Chemistry 246:129–136. doi: 10.1016/j.foodchem.2017.10.131.
248. Vijaya Saradhi, U. V., Y., Ling, J., Wang, M., Chiu, E. B., Schwartz, J. R., Fuchs, K. K., Chan, and Z., Liu. 2010. A liquid chromatography-tandem mass spectrometric method for quantification of curcuminoids in cell medium and mouse plasma. Journal of Chromatography B 878 (30):3045–3051. doi: 10.1016/j.jchromb.2010.08.039.
249. Vincenzi, S., D., Tomasi, F., Gaiotti, L., Lovat, S., Giacosa, F., Torchio, S., Rio Segade, and L., Rolle. 2013. Comparative study of the resveratrol content of twenty-one Italian red grape varieties. South African Journal for Enology and Viticulture 34 (1):30–34.
250. Wahlström, B., and G., Blennow. 1978. A study on the fate of curcumin in the rat. Acta Pharmacologica et Toxicologica 43 (2):86–92.
251. Walker, J., K., Schueller, L. M., Schaefer, M., Pignitter, L., Esefelder, and V., Somoza. 2014. Resveratrol and its metabolites inhibit pro-inflammatory effects of lipopolysaccharides in U-937 macrophages in plasma-representative concentrations. Food Function 5 (1):74–84. doi: 10.1039/C3FO60236B.
252. Walle, T., F., Hsieh, M. H., DeLegge, J. E., Oatis, and U. K., Walle. 2004. High absorption but very low bioavailability of oral resveratrol in humans. Drug Metabolism and Disposition: The Biological Fate of Chemicals 32 (12):1377–1382.
253. Walle, T., U. K., Walle, and P. V., Halushka. 2001. Carbon dioxide is the major metabolite of quercetin in humans. The Journal of Nutrition 131 (10):2648–2652.
254. Wang, J., M. G., Ferruzzi, L., Ho, J., Blount, E. M., Janle, B., Gong, Y., Pan, G. A., Gowda, D., Raftery, I., Arrieta-Cruz, V., et al. 2012. Brain-targeted proanthocyanidin metabolites for Alzheimer's disease treatment. The Journal of Neuroscience 32 (15):5144–5150. doi: 10.1523/JNEUROSCI.6437-11.2012.
255. Wang, P., and S., Sang. 2018. Metabolism and pharmacokinetics of resveratrol and pterostilbene. Biofactors (Oxford, England) 44 (1):16–25.
256. Wang, W., C., Sun, L., Mao, P., Ma, F., Liu, J., Yang, and Y., Gao. 2016. The biological activities, chemical stability, metabolism and delivery systems of quercetin: A review. Trends in Food Science and Technology 56:21–38. doi: 10.1016/j.tifs.2016.07.004.
257. Wang, X. L., K. T., Kim, J. H., Lee, H. G., Hur, and S. I., Kim. 2004. C-ring cleavage of isoflavones daidzein and genistein by a newly-isolated human intestinal bacterium Eubacterium ramulus julong 601. Journal of Microbiology and Biotechnology 14:766–771.
258. Wang, Y., Z., Qiu, B., Zhou, C., Liu, J., Ruan, Q., Yan, J., Liao, and F., Zhu. 2015. In vitro antiproliferative and antioxidant effects of urolithin A, the colonic metabolite of ellagic acid, on hepatocellular carcinomas HepG2 cells. Toxicology in Vitro 29 (5):1107–1115. doi: 10.1016/j.tiv.2015.04.008.
259. Warpe, V. S., V. R., Mali, S., Arulmozhi, S. L., Bodhankar, and K. R., Mahadik. 2015. Cardioprotective effect of ellagic acid on doxorubicin induced cardiotoxicity in wistar rats. Journal of Acute Medicine 5 (1):1–8. doi: 10.1016/j.jacme.2015.02.003.
260. Williamson, G., and M. N., Clifford. 2017. Role of the small intestine, colon and microbiota in determining the metabolic fate of polyphenols. Biochemical Pharmacology 139:24–39. doi: 10.1016/j.bcp.2017.03.012.
261. Wolfram, E., and A., Trifan. 2018. Computational aids for assessing bioactivities. In Computational phytochemistry, ed. S. D., Sarker and L., Nahar, 277–300. Amsterdam, Oxford, Cambridge: Elsevier.
262. Wu, J. C., C. S., Lai, V., Badmaev, K., Nagabhushanam, C. T., Ho, and M. H., Pan. 2011. Tetrahydrocurcumin, a major metabolite of curcumin, induced autophagic cell death through coordinative modulation of PI3K/Akt-mTOR and MAPK signaling pathways in human leukemia HL-60 cells. Molecular Nutrition & Food Research 55 (11):1646–1654. doi: 10.1002/mnfr.201100454.
263. Wu, Q., P. W., Needs, Y., Lu, P. A., Kroon, D., Ren, and X., Yang. 2018. Different antitumor effects of quercetin, quercetin-3’-sulfate and quercetin-3-glucuronide in human breast cancer MCF-7 cells. Food & Function 9 (3):1736. doi: 10.1039/C7FO01964E.
264. Xiao, J. B., and P., Högger. 2013. Metabolism of dietary flavonoids in liver microsomes. Current Drug Metabolism 14 (4):381–391.
265. Xiao, J. B., and P., Högger. 2015. Stability of dietary polyphenols under the cell culture condition: Avoiding erroneous conclusions. Journal of Agricultural and Food Chemistry 63 (5):1547–1557. doi: 10.1021/jf505514d.
266. Xiao, J. B. 2018. Stability of dietary polyphenols: It's never too late to mend? Food and Chemical Toxicology: An International Journal Published for the British Industrial Biological Research Association 119:3–5.
267. Yang, K. Y., L. C., Lin, T. Y., Tseng, S. C., Wang, and T. H., Tsai. 2007. Oral bioavailability of curcumin in rat and the herbal analysis from Curcuma longa by LC-MS/MS. Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences 853 (1–2):183–189.
268. Yao, J., L., Zhao, Z., Mao, S., Chen, K., Wong, J., To, and R. D., Brinton. 2013. Potentation of brain mitochondrial function by S-equol and R/S-equol estrogen receptor β selective PhytoSERM treatments. Brain Research 1514:128–141. doi: 10.1016/j.brainres.2013.02.021.
269. Yin, P., L., Yang, Q., Xue, M., Yu, F., Yao, L., Sun, and Y., Liu. 2017. Identification and inhibitory activities of ellagic acid- and kaemferol-derivatives from mongolian oak cups against α-glucosidase, α-amylase and protein glycation linked to type II diabetes and its complications and their influence on HepG2 cells’ viability. Arabian Journal of Chemistry 11 (8): 1247–1259. doi: 10.1016/j.arabjc.2017.10.002
270. 2. Food Chemistry 237:1101–1111. doi: 10.1016/j.foodchem.2017.06.021.
271. Yokoyama, S., and T., Suzuki. 2008. Isolation and characterization of a novel equol-producing bacterium from human feces. Bioscience, Biotechnology, and Biochemistry 72 (10):2660–2666. doi: 10.1271/bbb.80329.
272. Yoysungnoen, P., P., Wirachwong, C., Changtam, A., Suksamrarn, and S., Patumraj. 2008. Anti-cancer and anti-angiogenic effects of curcumin and tetrahydrocurcumin on implanted hepatocellular carcinoma in nude mice. World Journal of Gastroenterology 14 (13):2003–2009. doi: 10.3748/wjg.14.2003.
273. Yuan, J. P., J. H., Wang, and X., Liu. 2007. Metabolism of dietary soy isoflavones to equol by human intestinal microflora-implications for health. Molecular Nutrition & Food Research 51 (7):765–781.
274. Zamora-Ros, R., C., Andres-Lacueva, M., Lamuelo-Raventos, T., Berenguer, P., Jakszyn, C., Martínez, M. J., Sánchez, C., Navarro, M. D., Chirlaque, M. J., Tormo, et al. 2008. Concentrations of resveratrol and derivatives in foods and estimation of dietary intake in a spanish population: European prospective investigation into cancer and nutrition (EPIC)-Spain cohort. British Journal of Nutrition 100 (1):188–196.
275. Zeka, K., K., Ruparelia, R. R. J., Arroo, R., Budriesi, and M., Micucci. 2017. Flavonoids and their metabolites: prevention in cardiovascular diseases and diabetes. Diseases 5:19. doi: 10.3390/diseases5030019.
276. Zhang, L., J., Ma, K., Pan, V. L., Go, J., Chen, and W. C., You. 2005. Efficacy of cranberry juice on Helicobacter pylori infection: a double-blind, randomized placebo-controlled trial. Helicobacter 10 (2):139–145. doi: 10.1111/j.1523-5378.2005.00301.x.
277. Zhang, L., Y., Wang, D., Li, C. T., Ho, J., Li, and X., Wan. 2016. The absorption, distribution, metabolism and excretion of procyanidins. Food & Function 7 (3):1273–1281. doi: 10.1039/C5FO01244A.
278. Zhou, B., J., Wang, G., Zheng, and Z., Qiu. 2016. Methylated urolithin A, the modified ellagitannin-derived metabolite, suppresses cell viability of DU145 human prostate cancer cells via targeting miR-21. Food and Chemical Toxicology 97:375–384. doi: 10.1016/j.fct.2016.10.005.
279. Zhu, F. 2018. Proanthocyanidins in cereals and pseudocereals. Critical Reviews in Food Science and Nutrition 30:1–13. doi: 10.1080/10408398.2017.1418284.